The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2020

Filed:

Jan. 20, 2015
Applicant:

Octapharma Ag, Lachen, CH;

Inventors:

Stefan Winge, Stockholm, SE;

Marina Dadaian, Stockholm, SE;

Erica Johansson, Stockholm, SE;

Birte Fuchs, Berlin, DE;

Assignee:

OCTAPHARMA AG, Lache, CH;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/755 (2006.01); C07K 1/22 (2006.01); C07K 1/18 (2006.01); A61K 38/37 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/755 (2013.01); C07K 1/22 (2013.01); A61K 38/00 (2013.01);
Abstract

A process for manufacturing of a Factor VIII product having a ratio of FVIII:C/FVIII:Ag of at least 0.7 in the Factor VIII product by using chromatography wherein at least one chromatographic step is performed by means of employing; An affinity chromatography resin having an affinity for specifically binding of Factor VIII which is effected by an affinity ligand which is immobilised on the affinity chromatography resin, said affinity ligand is a 13 kD yeast derived Fab antibody fragment directed to the Factor VIII molecule. An anionic chromatography resin. A size exclusion resin. A Factor VIII product obtainable according to the process with a monomer content of >98% for treatment of haemophilia and avoiding formation of inhibitors.


Find Patent Forward Citations

Loading…